Humatrope 6 mg Norge - norsk - Statens legemiddelverk

humatrope 6 mg

eli lilly norge as - somatropin - pulver og væske til injeksjonsvæske, oppløsning - 6 mg

Humatrope 12 mg Norge - norsk - Statens legemiddelverk

humatrope 12 mg

eli lilly norge as - somatropin - pulver og væske til injeksjonsvæske, oppløsning - 12 mg

Humatrope 24 mg Norge - norsk - Statens legemiddelverk

humatrope 24 mg

eli lilly norge as - somatropin - pulver og væske til injeksjonsvæske, oppløsning - 24 mg

Solvivo 0.6 mg / 1.2 mg Norge - norsk - Statens legemiddelverk

solvivo 0.6 mg / 1.2 mg

geiser pharma s.l. - amylmetakresol / 2,4-diklorbenzylalkohol - sugetablett med mintsmak - 0.6 mg / 1.2 mg

Solvivo 0.6 mg / 1.2 mg Norge - norsk - Statens legemiddelverk

solvivo 0.6 mg / 1.2 mg

geiser pharma s.l. - amylmetakresol / 2,4-diklorbenzylalkohol - sugetablett med honning- og sitronsmak - 0.6 mg / 1.2 mg

Triolif Norge - norsk - Statens legemiddelverk

triolif

karo pharma as - lidokainhydrokloridmonohydrat / amylmetakresol / 2,4-diklorbenzylalkohol - sugetablett med honning- og sitronsmak - 2 mg / 0.6 mg / 1.2 mg

Triolif Norge - norsk - Statens legemiddelverk

triolif

karo pharma as - lidokainhydrokloridmonohydrat / amylmetakresol / 2,4-diklorbenzylalkohol - sugetablett med appelsinsmak - 2 mg / 0.6 mg / 1.2 mg

Triolif Norge - norsk - Statens legemiddelverk

triolif

karo pharma as - lidokainhydrokloridmonohydrat / amylmetakresol / 2,4-diklorbenzylalkohol - sugetablett med mintsmak - 2 mg / 0.6 mg / 1.2 mg

Ngenla Den europeiske union - norsk - EMA (European Medicines Agency)

ngenla

pfizer europe ma eeig - somatrogon - growth and development - hypofysen og hypothalamus hormoner og analoger - indicated for the long-term treatment of paediatric patients with growth disturbance due to insufficient secretion of growth hormone.

Teriparatide Sun Den europeiske union - norsk - EMA (European Medicines Agency)

teriparatide sun

sun pharmaceutical industries europe b.v. - teriparatide - osteoporosis; osteoporosis, postmenopausal - kalsiumhomeostase - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.